Skip to main content

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers.

Publication ,  Journal Article
Loring, Z; North, R; Hellkamp, AS; Atwater, BD; Frazier-Mills, CG; Jackson, KP; Pokorney, SD; Lamas, GA; Piccini, JP
Published in: Pacing Clin Electrophysiol
December 2020

BACKGROUND: Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most implanted LPs provide right ventricular pacing without atrioventricular synchrony (VVIR mode). The Mode Selection Trial in Sinus Node Dysfunction (MOST) showed similar outcomes in patients randomized to dual-chamber (DDDR) versus ventricular pacing (VVIR). We compared outcomes by pacing mode in LP-eligible patients from MOST. METHODS: Patients enrolled in the MOST study with an left ventricular ejection fraction (LVEF) >35%, QRS duration (QRSd) <120 ms and no history of ventricular arrhythmias or prior implantable cardioverter defibrillators were included (LP-eligible population). Cox proportional hazards models were used to test the association between pacing mode and death, stroke or heart failure (HF) hospitalization and atrial fibrillation (AF). RESULTS: Of the 2010 patients enrolled in MOST, 1284 patients (64%) met inclusion criteria. Baseline characteristics were well balanced across included patients randomized to DDDR (N = 630) and VVIR (N = 654). Over 4 years of follow-up, there was no association between pacing mode and death, stroke or HF hospitalization (VVIR HR 1.28 [0.92-1.75]). VVIR pacing was associated with higher risk of AF (HR 1.32 [1.08-1.61], P = .007), particularly in patients with no history of AF (HR 2.38 [1.52-3.85], P < .001). CONCLUSION: In patients without reduced LVEF or prolonged QRSd who would be eligible for LP, DDDR, and VVIR pacing demonstrated similar rates of death, stroke or HF hospitalization; however, VVIR pacing significantly increased the risk of AF development.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pacing Clin Electrophysiol

DOI

EISSN

1540-8159

Publication Date

December 2020

Volume

43

Issue

12

Start / End Page

1461 / 1466

Location

United States

Related Subject Headings

  • United States
  • Sick Sinus Syndrome
  • Pacemaker, Artificial
  • Male
  • Humans
  • Female
  • Equipment Design
  • Cardiovascular System & Hematology
  • Cardiac Pacing, Artificial
  • Atrial Fibrillation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Loring, Z., North, R., Hellkamp, A. S., Atwater, B. D., Frazier-Mills, C. G., Jackson, K. P., … Piccini, J. P. (2020). VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing Clin Electrophysiol, 43(12), 1461–1466. https://doi.org/10.1111/pace.14100
Loring, Zak, Rebecca North, Anne S. Hellkamp, Brett D. Atwater, Camille G. Frazier-Mills, Kevin P. Jackson, Sean D. Pokorney, Gervasio A. Lamas, and Jonathan P. Piccini. “VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers.Pacing Clin Electrophysiol 43, no. 12 (December 2020): 1461–66. https://doi.org/10.1111/pace.14100.
Loring Z, North R, Hellkamp AS, Atwater BD, Frazier-Mills CG, Jackson KP, et al. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing Clin Electrophysiol. 2020 Dec;43(12):1461–6.
Loring, Zak, et al. “VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers.Pacing Clin Electrophysiol, vol. 43, no. 12, Dec. 2020, pp. 1461–66. Pubmed, doi:10.1111/pace.14100.
Loring Z, North R, Hellkamp AS, Atwater BD, Frazier-Mills CG, Jackson KP, Pokorney SD, Lamas GA, Piccini JP. VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing Clin Electrophysiol. 2020 Dec;43(12):1461–1466.

Published In

Pacing Clin Electrophysiol

DOI

EISSN

1540-8159

Publication Date

December 2020

Volume

43

Issue

12

Start / End Page

1461 / 1466

Location

United States

Related Subject Headings

  • United States
  • Sick Sinus Syndrome
  • Pacemaker, Artificial
  • Male
  • Humans
  • Female
  • Equipment Design
  • Cardiovascular System & Hematology
  • Cardiac Pacing, Artificial
  • Atrial Fibrillation